Welcome back Rounds Table Listeners!
This week we are going back to our Rapid Fire Format to review two papers looking at potential SARS-CoV-2 vaccines.
- What is the safety profile and immune system response for a novel SARS-CoV-2 specific vaccine? https://www.nejm.org/doi/full/10.1056/NEJMoa2022483 (1:05-8:44)
- What is the safety, reactogenicity, and immunogenicity of a viral vectored coronavirus vaccine that expresses the spike protein of SARS-CoV-2? https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31604-4/fulltext (8:45-20:31)
And for the Good Stuff:
- No further description needed, just a guy painting a portrait of himself, painting a portrait of himself, on repeat: https://digg.com/2020/guy-paints-himself-painting-himself-over-and-over
- A nice review on why we should drink coffee from NEJM: https://www.nejm.org/doi/full/10.1056/NEJMra1816604
Questions? Comments? Feedback? We’d love to hear from you. @roundstable
A short review on immunology, a reminder about the ‘lasting’ effect from the CD4 T cell response to an immunization, and an informative review of two vaccine studies, notably the one from the Oxford group. Thanks so much!